Literature DB >> 9930151

Nuclear matrix proteins and their potential applications to diagnostic pathology.

J H Hughes1, M B Cohen.   

Abstract

The nuclear matrix is the nonchromatin scaffolding of the cell nucleus that confers nuclear shape, organizes the nuclear chromatin, and regulates many important intranuclear biochemical events. Although our understanding of the nuclear matrix and its proteins is still evolving, it is clear that nuclear matrix proteins (NMPs) hold considerable promise as diagnostic tools for pathologists. Early evidence suggests that NMPs may be useful biomarkers of neoplastic disease in serum, body fluids, and tissues. NMPs are also potential candidates for use as tumor prognostic factors and targets of anticancer drugs. Moreover, NMPs may hold the key to understanding important cellular events, such as neoplastic transformation, steroid hormone binding, and apoptosis. Despite impressive gains made by cellular biologists and biochemists toward understanding the structure and function of the nuclear matrix, many of the potential applications of NMPs to diagnostic pathology are largely unexplored. Thus, NMPs should prove an exciting and fruitful area of investigation for experimental and clinical pathologists who are interested in developing diagnostic tests for detecting, quantitating, and characterizing these proteins in human tissues and body fluids and translating these applications into the clinical pathology laboratory.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9930151     DOI: 10.1093/ajcp/111.2.267

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  4 in total

1.  Interaction of the nuclear matrix protein NAKAP with HypA and huntingtin: implications for nuclear toxicity in Huntington's disease pathogenesis.

Authors:  Jonathan A Sayer; Maria Manczak; Lakshmi Akileswaran; P Hemachandra Reddy; Vincent M Coghlan
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

2.  HCC-DETECT: a combination of nuclear, cytoplasmic, and oncofetal proteins as biomarkers for hepatocellular carcinoma.

Authors:  Abdelfattah M Attallah; Mohamed El-Far; Camelia A Abdel Malak; Mohamed M Omran; Gamal E Shiha; Khaled Farid; Lamiaa A Barakat; Mohamed S Albannan; Ahmed A Attallah; Mohamed A Abdelrazek; Mohamed S Elbendary; Refaat Sabry; Gehan A Hamoda; Mohamed M Elshemy; Abdallah A Ragab; Basma M Foda; Sanaa O Abdallah
Journal:  Tumour Biol       Date:  2015-05-01

3.  Non-small cell lung carcinoma: cyclin D1, bcl-2, p53, Ki-67 and HER-2 proteins expression in resected tumors.

Authors:  Svjetlana Radović; Mirsad Babić; Mirsad Dorić; Ajna Hukić; Suada Kuskunović; Ademir Hadzismajlović; Fadila Serdarević
Journal:  Bosn J Basic Med Sci       Date:  2007-08       Impact factor: 3.363

4.  Serum early prostate cancer antigen (EPCA) level and its association with disease progression in prostate cancer in a Chinese population.

Authors:  Zhigang Zhao; Wenjing Ma; Guohua Zeng; Defeng Qi; Lili Ou; Yeping Liang
Journal:  PLoS One       Date:  2011-05-03       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.